A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata

Documenti analoghi

• Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
  di: Brett Hauber, et al.
  Pubblicazione: (2025)
• Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
  di: Ogechi Ezemma, et al.
  Pubblicazione: (2024)
• SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
  di: Ziad Reguiai, et al.
  Pubblicazione: (2025)
• Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience
  di: Youyu Sheng, et al.
  Pubblicazione: (2025)
• Alopecia areata and ritlecitinib: Unravelling response trajectories
  di: Julien Seneschal
  Pubblicazione: (2025)